Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元，同比增加71.46%

市场透视11-09

11月9日，Cormedix Inc.（CRMD.US）公布财报，公告显示公司2024财年第三财季净利润为-2.78百万美元，同比增加71.46%；其中营业收入为11.46百万美元，每股基本收益为-0.05美元。从资产负债表来看，Cormedix Inc.（CRMD.US）总负债18.87百万美元，其中短期债务163449.00美元，资产负债比为4.12，流动比率为3.96。机构评级：截至2024...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2482485927?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-09 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2482485927","market":"us","top_or_hot":-1,"title":"Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元，同比增加71.46%","media":"市场透视","content":"<div>\n<p>11月9日，Cormedix Inc.（CRMD.US）公布财报，公告显示公司2024财年第三财季净利润为-2.78百万美元，同比增加71.46%；其中营业收入为11.46百万美元，每股基本收益为-0.05美元。从资产负债表来看，Cormedix Inc.（CRMD.US）总负债18.87百万美元，其中短期债务163449.00美元，资产负债比为4.12，流动比率为3.96。机构评级：截至2024...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cormedix Inc.2024财年第三财季实现净利润-2.78百万美元，同比增加71.46%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCormedix Inc.2024财年第三财季实现净利润-2.78百万美元，同比增加71.46%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-09 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月9日，Cormedix Inc.（CRMD.US）公布财报，公告显示公司2024财年第三财季净利润为-2.78百万美元，同比增加71.46%；其中营业收入为11.46百万美元，每股基本收益为-0.05美元。从资产负债表来看，Cormedix Inc.（CRMD.US）总负债18.87百万美元，其中短期债务163449.00美元，资产负债比为4.12，流动比率为3.96。机构评级：截至2024...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CRMD","symbol_name":"CorMedix Inc.","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b","article_id":"2482485927","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000030abae6d8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2482485927","pubTimestamp":1731081621,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月9日，Cormedix Inc.公布财报，公告显示公司2024财年第三财季净利润为-2.78百万美元，同比增加71.46%；其中营业收入为11.46百万美元，每股基本收益为-0.05美元。从资产负债表来看，Cormedix Inc.总负债18.87百万美元，其中短期债务163449.00美元，资产负债比为4.12，流动比率为3.96。机构评级：截至2024年11月9日，当前有5家机构对Cormedix Inc.目标价做出预测，其中目标均价为17.00美元，其中最低目标价为11.00美元，最高目标价为20.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"CRMD":"CorMedix Inc."},"translate_title":"Cormedix Inc. achieved net profit of-2.78 million US dollars in the third fiscal quarter of fiscal year 2024, a year-on-year increase of 71.46%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CRMD":0.9},"content_text":"11月9日，Cormedix Inc.（CRMD.US）公布财报，公告显示公司2024财年第三财季净利润为-2.78百万美元，同比增加71.46%；其中营业收入为11.46百万美元，每股基本收益为-0.05美元。从资产负债表来看，Cormedix Inc.（CRMD.US）总负债18.87百万美元，其中短期债务163449.00美元，资产负债比为4.12，流动比率为3.96。机构评级：截至2024年11月9日，当前有5家机构对Cormedix Inc.目标价做出预测，其中目标均价为17.00美元，其中最低目标价为11.00美元，最高目标价为20.00美元。公司简介：Cormedix Inc 是一家生物制药公司，专注于开发和商业化用于预防和治疗传染病和炎症性疾病的治疗产品。 该公司的主要重点是开发其主要候选产品 DefenCath，以在美国（美国）和其他主要市场实现潜在的商业化。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482485927"}